174 related articles for article (PubMed ID: 23337092)
1. The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome.
Antshel KM; Hendricks K; Shprintzen R; Fremont W; Higgins AM; Faraone SV; Kates WR
J Pediatr; 2013 Jul; 163(1):187-93.e1. PubMed ID: 23337092
[TBL] [Abstract][Full Text] [Related]
2. Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.
Kates WR; Mariano MA; Antshel KM; Chandra S; Gamble H; Giordano M; MacMaster E; Mattar M; St Fleur D; Faraone SV; Fremont WP
Psychol Med; 2019 Aug; 49(11):1914-1922. PubMed ID: 30226117
[TBL] [Abstract][Full Text] [Related]
3. Gyrification differences in children and adolescents with velocardiofacial syndrome and attention-deficit/hyperactivity disorder: a pilot study.
Mous SE; Karatekin C; Kao CY; Gottesman II; Posthuma D; White T
Psychiatry Res; 2014 Feb; 221(2):169-71. PubMed ID: 24377834
[TBL] [Abstract][Full Text] [Related]
4. Comparing ADHD in velocardiofacial syndrome to idiopathic ADHD: a preliminary study.
Antshel KM; Faraone SV; Fremont W; Monuteaux MC; Kates WR; Doyle A; Mick E; Biederman J
J Atten Disord; 2007 Jul; 11(1):64-73. PubMed ID: 17606773
[TBL] [Abstract][Full Text] [Related]
5. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study.
Biederman J; Faraone S; Milberger S; Curtis S; Chen L; Marrs A; Ouellette C; Moore P; Spencer T
J Am Acad Child Adolesc Psychiatry; 1996 Mar; 35(3):343-51. PubMed ID: 8714323
[TBL] [Abstract][Full Text] [Related]
6. Predicting reading comprehension academic achievement in late adolescents with velo-cardio-facial (22q11.2 deletion) syndrome (VCFS): a longitudinal study.
Antshel K; Hier B; Fremont W; Faraone SV; Kates W
J Intellect Disabil Res; 2014 Oct; 58(10):926-39. PubMed ID: 24861691
[TBL] [Abstract][Full Text] [Related]
7. Predictors of persistent ADHD: an 11-year follow-up study.
Biederman J; Petty CR; Clarke A; Lomedico A; Faraone SV
J Psychiatr Res; 2011 Feb; 45(2):150-5. PubMed ID: 20656298
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report.
Zagursky K; Weller RA; Jessani N; Abbas J; Weller EB
Curr Psychiatry Rep; 2006 Apr; 8(2):102-7. PubMed ID: 16539884
[TBL] [Abstract][Full Text] [Related]
9. Manic symptoms and behavioral dysregulation in youth with velocardiofacial syndrome (22q11.2 deletion syndrome).
Aneja A; Fremont WP; Antshel KM; Faraone SV; AbdulSabur N; Higgins AM; Shprintzen R; Kates WR
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):105-14. PubMed ID: 17343558
[TBL] [Abstract][Full Text] [Related]
10. Predictors of adolescent outcomes among 4-6-year-old children with attention-deficit/hyperactivity disorder.
Lahey BB; Lee SS; Sibley MH; Applegate B; Molina BSG; Pelham WE
J Abnorm Psychol; 2016 Feb; 125(2):168-181. PubMed ID: 26854503
[TBL] [Abstract][Full Text] [Related]
11. A 9-Year Follow-Up of Attention-Deficit/Hyperactivity Disorder in a Population Sample.
Lecendreux M; Silverstein M; Konofal E; Cortese S; Faraone SV
J Clin Psychiatry; 2019 May; 80(3):. PubMed ID: 31087826
[TBL] [Abstract][Full Text] [Related]
12. The effect of methylphenidate on prefrontal cognitive functioning, inattention, and hyperactivity in velocardiofacial syndrome.
Green T; Weinberger R; Diamond A; Berant M; Hirschfeld L; Frisch A; Zarchi O; Weizman A; Gothelf D
J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):589-95. PubMed ID: 22149470
[TBL] [Abstract][Full Text] [Related]
13. Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS).
Fabbro A; Rizzi E; Schneider M; Debbane M; Eliez S
Eur Child Adolesc Psychiatry; 2012 Jul; 21(7):379-85. PubMed ID: 22526976
[TBL] [Abstract][Full Text] [Related]
14. Predictors of persistence in girls with attention deficit hyperactivity disorder: results from an 11-year controlled follow-up study.
Biederman J; Petty CR; O'Connor KB; Hyder LL; Faraone SV
Acta Psychiatr Scand; 2012 Feb; 125(2):147-56. PubMed ID: 22097933
[TBL] [Abstract][Full Text] [Related]
15. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?
Papolos DF; Faedda GL; Veit S; Goldberg R; Morrow B; Kucherlapati R; Shprintzen RJ
Am J Psychiatry; 1996 Dec; 153(12):1541-7. PubMed ID: 8942449
[TBL] [Abstract][Full Text] [Related]
16. [Formula: see text]Executive functioning and its relation to ASD and ADHD symptomatology in 22q11.2 deletion syndrome.
de Sonneville LMJ; Hidding E; van Engeland H; Vorstman JAS; Sijmens-Morcus MEJ; Swaab H
Child Neuropsychol; 2018 Jan; 24(1):1-19. PubMed ID: 27608887
[TBL] [Abstract][Full Text] [Related]
17. ASD, ADHD, mental health conditions and psychopharmacology in neurogenetic syndromes: parent survey.
Reilly C; Senior J; Murtagh L
J Intellect Disabil Res; 2015 Apr; 59(4):307-18. PubMed ID: 24965264
[TBL] [Abstract][Full Text] [Related]
18. Analysis of personal and family factors in the persistence of attention deficit hyperactivity disorder: results of a prospective follow-up study in childhood.
Miranda A; Colomer C; Fernández MI; Presentación MJ; Roselló B
PLoS One; 2015; 10(5):e0128325. PubMed ID: 26024216
[TBL] [Abstract][Full Text] [Related]
19. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
[TBL] [Abstract][Full Text] [Related]
20. A 4-year follow-up of attention-deficit/hyperactivity disorder in a population sample.
Lecendreux M; Konofal E; Cortese S; Faraone SV
J Clin Psychiatry; 2015 Jun; 76(6):712-9. PubMed ID: 26132672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
